These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33852451)

  • 1. Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Gil-Gómez A; Ampuero J; Rojas Á; Gallego-Durán R; Muñoz-Hernández R; Rico MC; Millán R; García-Lozano R; Francés R; Soriano G; Romero-Gómez M
    Am J Gastroenterol; 2021 Jun; 116(6):1238-1247. PubMed ID: 33852451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study associating glutaminase promoter variations with hepatic encephalopathy in East Asian populations.
    Ahn JM; Kim CH; Um SH; Kim KM; Kim TH; Yim SY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2017 Apr; 32(4):901-907. PubMed ID: 27749985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients.
    Jepsen P; Watson H; Andersen PK; Vilstrup H
    J Hepatol; 2015 Nov; 63(5):1133-8. PubMed ID: 26206073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Tapper EB; Zhao L; Nikirk S; Baki J; Parikh ND; Lok AS; Waljee AK
    Am J Gastroenterol; 2020 Dec; 115(12):2017-2025. PubMed ID: 32773463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis.
    Tapper EB; Parikh ND; Sengupta N; Mellinger J; Ratz D; Lok AS; Su GL
    Hepatology; 2018 Oct; 68(4):1498-1507. PubMed ID: 29091289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the promoter region of the glutaminase gene and the development of hepatic encephalopathy in patients with cirrhosis: a cohort study.
    Romero-Gómez M; Jover M; Del Campo JA; Royo JL; Hoyas E; Galán JJ; Montoliu C; Baccaro E; Guevara M; Córdoba J; Soriano G; Navarro JM; Martínez-Sierra C; Grande L; Galindo A; Mira E; Mañes S; Ruiz A
    Ann Intern Med; 2010 Sep; 153(5):281-8. PubMed ID: 20820037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis.
    Bai Z; Bernardi M; Yoshida EM; Li H; Guo X; Méndez-Sánchez N; Li Y; Wang R; Deng J; Qi X
    Aging (Albany NY); 2019 Oct; 11(19):8502-8525. PubMed ID: 31596729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
    Romero-Gómez M; Córdoba J; Jover R; del Olmo JA; Ramírez M; Rey R; de Madaria E; Montoliu C; Nuñez D; Flavia M; Compañy L; Rodrigo JM; Felipo V
    Hepatology; 2007 Apr; 45(4):879-85. PubMed ID: 17393525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Pantham G; Post A; Venkat D; Einstadter D; Mullen KD
    Dig Dis Sci; 2017 Aug; 62(8):2166-2173. PubMed ID: 28560484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genetic variant in the promoter of phosphate-activated glutaminase is associated with hepatic encephalopathy.
    Mayer LB; Krawczyk M; Grünhage F; Lammert F; Stokes CS
    J Intern Med; 2015 Sep; 278(3):313-22. PubMed ID: 25880019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Riggio O; Amodio P; Farcomeni A; Merli M; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Piazza N; De Rui M; Schiff S; Montagnese S
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1346-52. PubMed ID: 25572976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Nardelli S; Lattanzi B; Merli M; Farcomeni A; Gioia S; Ridola L; Riggio O
    Hepatology; 2019 Nov; 70(5):1704-1713. PubMed ID: 31038758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
    Bajaj JS; Thacker LR; Heuman DM; Sterling RK; Stravitz RT; Sanyal AJ; Luketic V; Fuchs M; Gilles HC; Wade JB
    Liver Transpl; 2012 Oct; 18(10):1179-87. PubMed ID: 22674517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
    Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
    Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE).
    Formentin C; Zarantonello L; Mangini C; Frigo AC; Montagnese S; Merkel C
    Liver Int; 2021 May; 41(5):1070-1082. PubMed ID: 33411388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
    Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.